These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11396710)

  • 21. AMIODARONE AND THYROID DYSFUNCTION.
    Medić F; Bakula M; Alfirević M; Bakula M; Mucić K; Marić N
    Acta Clin Croat; 2022 Aug; 61(2):327-341. PubMed ID: 36818930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy.
    Bogazzi F; Bartalena L; Dell'Unto E; Tomisti L; Rossi G; Pepe P; Tanda ML; Grasso L; Macchia E; Aghini-Lombardi F; Pinchera A; Martino E
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):533-7. PubMed ID: 17561980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amiodarone-induced thyrotoxicosis: case report and review of the literature].
    Bianconcini M; Giannini AL
    Ital Heart J Suppl; 2003 Aug; 4(8):682-7. PubMed ID: 14655464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
    Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
    Irimie A; Piciu D
    Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone-induced thyroid disorders: a clinical review.
    Loh KC
    Postgrad Med J; 2000 Mar; 76(893):133-40. PubMed ID: 10684321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amiodarone effects on thyroid--current concepts].
    Campos MV
    Acta Med Port; 2004; 17(3):241-6. PubMed ID: 15929853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effects of amiodaron on the thyroid function].
    Kucharczyk P; Michałkiewicz D; Kucharczyk A
    Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [AMIODARONE AND THE THYROID FUNCTION].
    Jukić T; Punda M; Franceschi M; Staniĉić J; Granić R; Kusić Z
    Lijec Vjesn; 2015; 137(5-6):181-8. PubMed ID: 26380478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.
    Roti E; Minelli R; Gardini E; Bianconi L; Braverman LE
    Arch Intern Med; 1993 Apr; 153(7):886-92. PubMed ID: 8466380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis.
    Bogazzi F; Dell'Unto E; Tanda ML; Tomisti L; Cosci C; Aghini-Lombardi F; Sardella C; Pinchera A; Bartalena L; Martino E
    J Endocrinol Invest; 2006 Sep; 29(8):694-9. PubMed ID: 17033257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis.
    Roti E; Minelli R; Gardini E; Bianconi L; Gavaruzzi G; Ugolotti G; Neri TM; Braverman LE
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1273-7. PubMed ID: 1331165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical procedure in amiodarone-induced thyroid dysfunction].
    Różycka-Kosmalska M; Michalak R; Kosmalski M; Ptaszyński P; Wranicz JK; Zieleniewski W; Cygankiewicz I
    Pol Merkur Lekarski; 2016 Jan; 40(235):46-52. PubMed ID: 26891437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
    Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
    J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Trip MD; Wiersinga W; Plomp TA
    Am J Med; 1991 Nov; 91(5):507-11. PubMed ID: 1951413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.
    Bartalena L; Brogioni S; Grasso L; Bogazzi F; Burelli A; Martino E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2930-3. PubMed ID: 8768854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical value of regular thyroid function tests during amiodarone treatment.
    Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
    Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.